Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Solidpharma from Gent, company number BE0826168103, closed financial year 2025 with a result of € 163,718 after tax. For that financial year Solidpharma recorded a gross margin of € 1.1 million and equity of € 733,170. Compared with financial year 2024, the result moved from € 14,558 to € 163,718. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on January 3, 2026.
€ 733,170
▲ 29% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 163,718
▲ € 149,160 vs 2024
Profit after tax over the fiscal year.
€ 296,454
▲ 92% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 714,570.
People and assets in 2025
6
▼ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 610,717
▲ 8% vs 2024
€ 101,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 12,103
▲ 83% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 787,500
▼ 14% vs 2024
€ 22,929 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 552,422
▼ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 153,577
▼ 8% vs 2024
Taxes, VAT and social contributions still to pay.
| 2021 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 484,154 | € 1,067,594 | € 824,440 | € 1,140,033 | ▲ 38% |
| Profit after taxes | € 180,590 | € 228,679 | € 14,558 | € 163,718 | ▲ € 149,160 |
| Equity | € 326,216 | € 554,895 | € 569,453 | € 733,170 | ▲ 29% |
| Total debts | € 1,299,458 | € 1,648,795 | € 1,668,321 | € 1,548,087 | ▼ 7% |
| Cash | € 475,031 | € 327,185 | € 154,621 | € 296,454 | ▲ 92% |
| Land & buildings | € 871 | € 471 | € 188 | € 0 | ▼ 100% |
| Retained profit | € 307,616 | € 536,295 | € 550,853 | € 714,570 | ▲ 30% |
| Dividend | € 740,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 0 | € 937,500 | € 912,500 | € 787,500 | ▼ 14% |
| Balance sheet total | € 1,625,673 | € 2,203,690 | € 2,237,773 | € 2,281,257 | ▲ 2% |
| Employees (FTE) | 2.7 | 5.6 | 6.9 | 6 | ▼ 0.9 |
Key figures of Solidpharma, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 December 2026.
What happened to Solidpharma?
What happened at Solidpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 163,718 (▲ € 149,160 vs 2024). filed late Source: NBB ↗
- Namalno BV became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 180,590 profit in 2021 to € 163,718 profit in 2025.
Paid € 289,749 in corporate taxes since 2021.
Best year ever: 2023, with € 228,679 profit.
On average € 190,000 of value added per employee in 2025.
Management
The stake of Namalno comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SolidpharmaBehind Solidpharma is Namalno BV. The shares are held by Namalno (100%).
Directors
According to the 2025 annual accounts
Director · represented by Rogge FABRICE.
since 2020
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Heistraat 16
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0826.168.103
- VAT number
- BE 0826.168.103
- Registered office
- Heistraat 16, 9052 Gent
- Names & denominations
- Solidpharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 May 2010
- Peppol
- Active · Active since 5 Jan 2026
- Contact
- solidpharma.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Detailhandel in farmaceutische producten